Article

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials-12-01-2006
Volume0
Issue 0

U.S. Departments and Offices

Washington editor Jill Wechsler provides an updated list of U.S. regulatory agency personnel.

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office for Human Research Protection

Director

Bernard Schwetz (240) 453-6900

NIH Institutes, Center, and Divisions

Deputy Director and Director, Office of International Activities

Melody Lin (240) 453-8126

Associate Director, Regulatory Affairs

Michael Carome (240) 453-8237

Director, Division of Compliance Oversight

Kristina Borror (240) 453-8132

Director, Division of Education and Development

Shirley Hicks (240) 453-8227

Director, Division of Policy and Assurances

Irene Stith-Coleman (240) 453-8138

FOOD AND DRUG ADMINISTRATION

Office of the FDA Commissioner

Commissioner

Andrew von Eschenbach* (301) 827-3310

Deputy Commissioner for Operations

Janet Woodcock (301) 827-3310

Deputy Commissioner for Policy

Scott Gottlieb (301) 827-9776

Deputy Commissioner for International and Special Programs

Murray Lumpkin (301) 827-5709

Chief Staff Officer and Associate Commissioner for Legislation

Patrick Ronan (301) 827-0087

Chief Counsel

Sheldon Bradshaw (301) 827-1137

Senior Associate Commissioner for Policy, Planning

Randall Lutter (301) 827-5292

Associate Commissioner for Science and Health Coordination

Norris Alderson (301) 827-3340

Assistant Commissioner for Science and Deputy Director, Office of Science & Health Coordination

Linda Tollefson (301) 827-3340

Associate Commissioner for External Relations

Jason Brodsky (301) 827-6251

Associate Commissioner for Planning

Theresa Mullin (301) 827-5292

Associate Commissioner for Management and Chief Financial Officer

Kathleen Heuer (301) 255-6762

Assistant Commissioner for Policy

Jeffrey Shuren (301) 827-3360

Assistant Commissioner for Counterterrorism Policy

Boris Lushniak (301) 827-4067

Assistant Commissioner for International Programs

Melinda Plaisier (301) 827-4480

Assistant Commissioner for Women's Health

Kathleen Uhl (301) 827-0350

Director, Office of Crisis Management

Ellen Morrison (301) 827-5660

Director, Office of Combination Products

Mark Kramer (301) 427-1934

Director, Office of Orphan Products Development

Marlene Haffner (301) 827-3666

Director, Office of Pediatric Therapeutics

Dianne Murphy (301) 827-9218

Director, Office of Special Health Issues

Theresa Toigo (301) 827-4460

Senior Advisor for Clinical Science

David Lepay (301) 827-3340

Special Assistant to the Director

Patricia Beers Block (301) 827-3340

Associate Director for Human Subject Protection Policy

Bonnie Lee (301) 827-3340

Expert Consumer Safety Officer

Carolyn Hommel (301) 827-3340

Biophysicist

Jean Toth-Allen (301) 827-3340

Office of Regulatory Affairs

Associate Commissioner for Regulatory Affairs

Margaret Glavin (301) 827-3101

Deputy Commissioner for Compliance Policy

David Horowitz (301) 827-3101

Deputy Commissioner for Field Operations

Diana Kolaitis (718) 662-5416

Senior Advisor for Clinical Science

Lori Love (301) 827-3684

Center for Devices and Radiological Health

Director

Daniel Schultz (240) 276-3139

Deputy Director

Linda Kahan (240) 276-3139

Director, Office of Device Evaluation

Donna Bea Tillman (240) 276-3993

Director, Office of Compliance

Timothy Ulatowski (301) 276-0100

Director, Division of Bioresearch Monitoring

Michael Marcarelli (301) 276-0125

Director, Office of In Vitro Diagnostic Device Evaluation and Safety

Steven Gutman (240) 276-0484

Director, Office of Surveillance and Biometrics

Susan Gardner (240) 276-3351

Center for Drug Evaluation and Research (CDER)

Director

Steven Galson (301) 594-5400

Deputy Director

Douglas Throckmorton (301) 594-5400

Associate Director for Safety Policy and Communications

Paul Seligman (301) 443-5620

Drug Safety Oversight Board

Susan Cummins (301) 443-5284

Associate Director for Medical Informatics

Randy Levin (301) 827-7784

Associate Director for Regulatory Policy

Jane Axelrad (301) 594-5400

Director, Office of Executive Programs

Jane Ware* (301) 443-5293

Director, Office of Management

Russell Abbott (301) 594-6741

Director, Office of Training and Communication

Nancy Smith (301) 827-1651

Director, Office of Information Technology

James Shugars (301) 827-6240

Director, Office of Counter-Terrorism and Pediatric Drug Development

Rosemary Roberts (301) 796-7210

Office of Translational Services

Director

Shirley Murphy (301) 796-2600

Director, Office of Clinical Pharmacology and Biopharmaceutics

Lawrence Lesko (301) 796-2450

Director, Office of Biostatistics

Robert O'Neill (301) 827-3195

Office of Compliance

Director

Deborah Autor (301) 827-8910

Deputy Director

Joe Famulare* (301) 827-8910

Director, Division of Scientific Investigations

Joseph Salewski (301) 594-0020

Chief, Good Clinical Practices Branch I

Ni Khin (301) 827-7395

Chief, Good Clinical Practices Branch II

Leslie Ball (301) 827-5455

Chief, GLP/Bioequivalence Investigations Branch

C.T. Viswanathan (301) 594-0163

Office of Medical Policy

Director

Robert Temple (301) 796-2270

Deputy Director

Rachel Behrman (301) 796-2270

Director, Division of Drug Marketing, Advertising, and Communications

Thomas Abrams (301) 796-1200

Office of New Drugs

Director

John Jenkins (301) 796-0700

Deputy Director

Sandra Kweder (301) 796-0700

Director, Office of Drug Evaluation I

Robert Temple* (301) 796-2270

Director, Office of Drug Evaluation II

Robert Meyer (301) 796-2310

Director, Office of Drug Evaluation III

Julie Beitz (301) 796-0848

Director, Office of Antimicrobial Products

Mark Goldberger (301) 796-0720

Director, Office of Oncology Products

Richard Pazdur (301) 796-2340

Director, Office of Nonprescription Products

Charles Gamley (301) 796-2060

Office of Pharmaceutical Science

Director

Helen Winkle (301) 796-2400

Deputy Director

Keith Webber (301) 796-2400

Director, Office of New Drug Quality Assessment

Moheb Nasr (301) 796-1900

Director, Office of Generic Drugs

Gary Buehler (240) 276-9310

Director, Office of Testing and Research

Linda Bushe (314) 529-2134

Director, Office of Biotechnology Products

Steven Kozlowski (301) 796-2390

Office of Surveillance and Epidemiology

Director

Gerald Dal Pan (301) 796-2380

Center for Biologics Evaluation and Research (CBER)

Director

Jesse Goodman (301) 827-0372

Deputy Director, Medical

Karen Midthun (301) 827-0376

Associate Director for Policy

Diane Maloney (301) 827-0372

Associate Director for Research

Kathryn Carbone (301) 827-0377

Associate Director for Quality Assurance

Sheryl Lard-Whiteford (301) 827-0379

Associate Director for Review Management

Robert Yetter (301) 827-0373

Senior Policy Advisor and Counselor for Biologics

Jill Warner (301) 827-0372

Director, Office of Biostatistics and Epidemiology

Mary Foulkes (301) 827-3034

Director, Office of Communication, Training, and Manufacturers Assistance

Dennis Strickland* (301) 827-2000

Director, Office of Management

Joseph Biviano (301) 827-1320

Director, Office of Information Technology

Ginger Leo* (301) 827-1368

Director, Office of Blood Research and Review

Jay Epstein (301) 827-3518

Director, Office of Vaccines Research and Review

Norman Baylor (301) 827-0655

Director, Office of Cellular, Tissue, and Gene Therapies

Celia Witten (301) 827-6536

Director, Office of Compliance and Biologics Quality

Mary Anne Malarkey (301) 827-6190

Director, Division of Inspections and Surveillance

Gilliam Conley (301) 827-6220

Chief, Bioresearch Monitoring Branch

Patricia Holobaugh (301) 827-6220

*Acting

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.